Reducing radiation for neck cancer of unknown origin
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This study tests whether surgery can reduce the amount of radiation needed for HPV-related neck cancer that started from an unknown spot. If eligible, you may get a less intense radiation plan after a targeted surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of throat cancer that is HPV-related (p16 positive) and started in a neck lymph node, but the original tumor hasn't been found yet.
- You are 18 years or older and willing to join the study.
- You must be able to carry out daily activities with little help (ECOG score 0-2).
- The cancer is only in one lymph node on one side of your neck, smaller than 6 cm, based on scans.
- You must not have had any other active cancer (except certain skin or thyroid cancers) or head/neck cancer in the last 2 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether we can safely use lower doses of radiation for people with HPV-related throat cancer, while still targeting the areas that need it. The goal is to reduce side effects without lowering the chance of a cure.
This trial tests a lower dose of radiation to certain neck areas for people with HPV-related oropharyngeal cancer. The goal is to see if reducing radiation can cause fewer side effects while still curing the cancer.
This trial tests whether using a de-escalated (lower/intensity-reduced) radiation approach can treat HPV-positive oropharyngeal squamous cell carcinoma. It may help reduce side effects while still keeping the cancer under control.
This trial looks at whether giving less (de-escalated) radiation after surgery is as effective and safer for people with locally advanced head and neck squamous cell carcinoma who had a strong response to treatment before surgery. If you had no remaining cancer or only very small amounts of cancer left in the surgical specimen, this approach may help reduce side effects while keeping control of the disease.
This study looks at whether some people with HPV-positive throat/oropharynx cancer can safely receive a less intense form of radiation (and sometimes chemo) after surgery. It aims to reduce treatment burden while keeping the cancer under control, based on how high-risk the pathology looks.
This trial tests whether a lower dose of radiation to the neck is safe and effective for people with HPV-related oropharyngeal cancer. It may reduce side effects while still treating the cancer.
Hear when a new Head and Neck Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.